Explore evidence

31.5 %The frequency of moderate-to-severe neurocognitive impairment was 31.5%.

NigeriaVIH/sidapublished 2026Annals of African medicinePubMeddocument of 7 observations

48,260 tests_per_monthThe average number of monthly HIV tests was 48,260 in the post-transition period.

NigeriaVIH/sidapublished 2025BMC health services researchPubMeddocument of 9 observations

46.6 %The CYP2B6:516 G/T genotype frequency was 46.6% among participants with genotype results.

NigeriaVIH/sidapublished 2020Nigerian journal of clinical practicePubMeddocument of 8 observations

33.8 %The pediatric HIV disclosure rate in this study was 33.8%.

NigeriaVIH/sidapublished 2020Nigerian journal of clinical practicePubMeddocument of 2 observations

80.88 %The prevalence of viral load suppression (VLS) among people living with HIV on antiretroviral therapy in Nigeria was 80.88% according to the 2018 Nigeria HIV/AIDS Indicator and Impact Survey.

NigeriaVIH/sidaobserved 2018published 2023HIV medicinePubMeddocument of 5 observations

79.2 %Of the 24 HIV-infected children, 19 (79.2%) were less than 18 months old.

NigeriaVIH/sidapublished 2019The Pan African medical journalPubMeddocument of 4 observations

13.11 µmol/lThe mean plasma glutathione level was 13.11 ± 3.20 µmol/l in HIV uninfected children.

NigeriaVIH/sidapublished 2021West African journal of medicinePubMeddocument of 4 observations

1,900,000 peopleIn Nigeria, it was estimated that 1.9 million people were living with HIV.

NigeriaVIH/sidapublished 2022The Pan African medical journalPubMeddocument of 6 observations

10.3 %The prevalence of HBV among HIV-infected women of reproductive age in Benue State, Nigeria was 10.3%.

Nigeriahépatite B · VIH/sidapublished 2020PloS onePubMeddocument of 4 observations

843 clientsOf the 7483 clients tracked, 843 (11.2%) discontinued care.

NigeriaVIH/sidapublished 2019AIDS research and therapyPubMeddocument of 14 observations

HIV mono-infected patients had significantly lower alanine aminotransferase levels compared to HIV/HCV co-infected study participants.

Nigeriahépatite C · VIH/sidapublished 2021Annals of African medicinePubMeddocument of 3 observations

9.4 %The overall HIV positivity rate among key populations tested by SFH between 2019 and 2023 was 9.4%.

NigeriaVIH/sidaobserved 2019 - 2023published 2025PloS onePubMeddocument of 13 observations

7 %The proportion of HIV-negative individuals in Osun State, Nigeria with elevated 10-year cardiovascular risk was 7%.

Nigeriamaladies cardiovasculaires · VIH/sidapublished 2026BMC infectious diseasesPubMeddocument of 9 observations

0.4 AOREver use of psychoactive substance was associated with viral load suppression among HIV-positive clients (adjusted odds ratio 0.40; 95% CI 0.12–0.75).

NigeriaVIH/sidapublished 2022West African journal of medicinePubMeddocument of 7 observations

425 participantsIn a cross-sectional survey, 425 adult people living with HIV (PLHIVs) attending a tertiary hospital in Nigeria self-reported their 28-day adherence to highly active antiretroviral therapy (HAART).

NigeriaVIH/sidapublished 2020Ghana medical journalPubMeddocument of 7 observations

49.5 %Almost half (49.5%) of the study participants gained weight after ART initiation.

NigeriaVIH/sidapublished 2025Frontiers in public healthPubMeddocument of 7 observations

14 %HIV prevalence among MSM increased from 14% in 2007 to 17% in 2010 to 23% in 2014.

NigeriaVIH/sidaobserved 2007published 2019BMC public healthPubMeddocument of 12 observations

605 clientsA total of 605 newly-diagnosed clients were enrolled into the study.

NigeriaVIH/sidapublished 2025BMC public healthPubMeddocument of 8 observations

22.2 %OSS accounted for 22.2% of the 3737 patients with known viral load.

NigeriaVIH/sidaobserved May 2022 to May 2023published 2026BMC public healthPubMeddocument of 9 observations

3.27 cmLeft atrium dimension was significantly higher in HIV-positive subjects on HAART (3.27 cm).

NigeriaVIH/sidapublished 2021Cardiovascular journal of AfricaPubMeddocument of 9 observations

50 %Minor PI resistance-associated mutation L10V/I was identified in 50% of CRF02_AG HIV-1 isolates.

NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 11 observations

1,700,000 inhabitantsIn 2021, 1.7 million people living with HIV in Nigeria were on antiretroviral therapy (ART).

NigeriaVIH/sidaobserved 2021published 2024Journal of research in health sciencesPubMeddocument of 5 observations

64.4 %Majority of the study respondents had undergone premarital screening for HIV/AIDS (64.4%).

NigeriaVIH/sidapublished 2023West African journal of medicinePubMeddocument of 4 observations

Triple infection with HIV/HBV/HDV was associated with significantly lower CD4+ cell counts and worse clinical outcomes, including elevated liver enzymes and rapid progression to liver cancer.

Nigeriahépatite B · hepatitis D virus · VIH/sidapublished 2024VirusesPubMeddocument of 7 observations

50 %Only about 50% of the key populations in Nigeria were aware of HIV self-testing (HIVST) services.

NigeriaVIH/sidapublished 2021AIDS research and therapyPubMeddocument of 17 observations